Prostate drug linked to lower risk of Parkinson’s disease

A large observational study has revealed that taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson’s disease. The research, which was published in JAMA Neurology, indicated that terazosin and similar medications might have the potential to prevent or delay the development of Parkinson’s disease. This study included data from almost 300,000 older men and was obtained from two large, independent patient datasets – the Truven Health Analytics MarketScan database in the USA and national health registries in Denmark – to investigate whether taking terazosin is associated with the development of...